Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study PRS 313 identifies women predominantly at risk for developing ...
The blood or saliva test results can be used as a “risk enhancer” for patients who fall in treatment gray zones, study author ...
Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for risk of developing certain health conditions or traits that arise from more than ...
A new international study challenges the century‑old dominance of Mendelian genetics, arguing that most traits arise from ...
Three out of four U.S. adults support the use of emerging technologies that estimate a future child's likelihood of developing health conditions influenced by multiple genes - such as diabetes, heart ...
Professor James Tabery, Bioethicist at The University of Utah, joins Lisa Dent to discuss polygenic embryo screening that ...
Polygenic traits, which are shaped by numerous loci with minor effects, environmental factors, and epigenetic modifications, play a pivotal role in ...
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study The content of this manuscript does not necessarily reflect the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results